Literature DB >> 3355257

Value of joint scintigraphy in the prediction of erosiveness in early rheumatoid arthritis.

T T Möttönen1, P Hannonen, J Toivanen, A Rekonen, M Oka.   

Abstract

The value of scintigraphy in predicting development of new erosions in small peripheral joints was studied by visual evaluation of scintigrams and by three computerised methods. In 13 patients with newly diagnosed rheumatoid arthritis a total of 387 joints were examined clinically, scintigraphically, and radiographically. The follow up period was 24 months. Four eroded joints in three patients were found at the onset. Of the joints which were to become eroded, 46/47 were scintigraphically active at all the check ups. Erosions were detected earlier in foot joints than in finger joints. New erosions were especially prone to appear in joints with persisting and high scintigraphic activity. On the contrary, inactive joints by repeated scanning never eroded. Scintigraphic and clinical activity and radiographic erosiveness correlated significantly with each other. The sensitivity and specificity of visual scintigraphic assessment and the relative pixel activity method proved to be superior to the region of interest methods and clinical evaluation for prediction of erosiveness.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3355257      PMCID: PMC1003481          DOI: 10.1136/ard.47.3.183

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  18 in total

1.  DIAGNOSTIC criteria for rheumatoid arthritis: 1958 revision by a committee of the American Rheumatism Association.

Authors: 
Journal:  Ann Rheum Dis       Date:  1959-03       Impact factor: 19.103

2.  Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films.

Authors:  A Larsen; K Dale; M Eek
Journal:  Acta Radiol Diagn (Stockh)       Date:  1977-07

3.  Radiotechnetium polyphosphate joint imaging.

Authors:  M Desaulniers; A Fuks; D Hawkins; Y Lacourciere; L Rosenthall
Journal:  J Nucl Med       Date:  1974-06       Impact factor: 10.057

4.  Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis.

Authors:  D M Ritchie; J A Boyle; J M McInnes; M K Jasani; T G Dalakos; P Grieveson; W W Buchanan
Journal:  Q J Med       Date:  1968-07

5.  Radiographic changes in early rheumatoid disease.

Authors:  A Brook; M Corbett
Journal:  Ann Rheum Dis       Date:  1977-02       Impact factor: 19.103

6.  Joint scanning in rheumatoid arthritis: a literature review.

Authors:  D J Wallace; M Brachman; J R Klinenberg
Journal:  Semin Arthritis Rheum       Date:  1981-08       Impact factor: 5.532

7.  Prognostic value of early features in rheumatoid disease.

Authors:  A Fleming; J M Crown; M Corbett
Journal:  Br Med J       Date:  1976-05-22

8.  Rheumatoid arthritis: relation of serum C-reactive protein and erythrocyte sedimentation rates to radiographic changes.

Authors:  R S Amos; T J Constable; R A Crockson; A P Crockson; B McConkey
Journal:  Br Med J       Date:  1977-01-22

9.  Serum C1q levels as a prognostic guide to articular erosions in patients with rheumatoid arthritis.

Authors:  T Ochi; K Yonemasu; R Iwase; T Sasaki; K Tsuyama; K Ono
Journal:  Arthritis Rheum       Date:  1984-08

10.  A comparison of 99mTc-MDP and 99mTc-pertechnetate by computerized quantitative joint scintigraphy.

Authors:  M Oka; T Möttönen; A Rekonen
Journal:  Scand J Rheumatol       Date:  1983       Impact factor: 3.641

View more
  11 in total

1.  Current imaging strategies in rheumatoid arthritis.

Authors:  Merissa N Zeman; Peter Jh Scott
Journal:  Am J Nucl Med Mol Imaging       Date:  2012-03-28

Review 2.  Rheumatoid arthritis: Nuclear Medicine state-of-the-art imaging.

Authors:  Paulo Henrique Rosado-de-Castro; Sergio Augusto Lopes de Souza; Dângelo Alexandre; Lea Mirian Barbosa da Fonseca; Bianca Gutfilen
Journal:  World J Orthop       Date:  2014-07-18

3.  Magnetic resonance imaging, radiography, and scintigraphy of the finger joints: one year follow up of patients with early arthritis. The TIRA Group.

Authors:  M Klarlund; M Ostergaard; K E Jensen; J L Madsen; H Skjødt; I Lorenzen
Journal:  Ann Rheum Dis       Date:  2000-07       Impact factor: 19.103

Review 4.  Imaging in psoriatic arthritis.

Authors:  Allen Anandarajah
Journal:  Clin Rev Allergy Immunol       Date:  2013-04       Impact factor: 8.667

5.  Early detection of bony alterations in rheumatoid and erosive arthritis of finger joints with high-resolution single photon emission computed tomography, and differentiation between them.

Authors:  B Ostendorf; K Mattes-György; D C Reichelt; D Blondin; A Wirrwar; R Lanzman; H W Müller; M Schneider; U Mödder; A Scherer
Journal:  Skeletal Radiol       Date:  2010-01       Impact factor: 2.199

6.  Serum interleukin 6 levels in rheumatoid arthritis: correlations with clinical and laboratory indices of disease activity.

Authors:  R Madhok; A Crilly; J Watson; H A Capell
Journal:  Ann Rheum Dis       Date:  1993-03       Impact factor: 19.103

7.  Serum concentrations of soluble interleukin 2 receptor in patients with rheumatoid arthritis: effect of second line drugs.

Authors:  A Crilly; R Madhok; J Watson; H A Capell
Journal:  Ann Rheum Dis       Date:  1993-01       Impact factor: 19.103

8.  Value of 99mTc-IgG scintigraphy in the prediction of joint destruction in patients with rheumatoid arthritis of recent onset.

Authors:  M H de Bois; M L Westedt; J W Arndt; K S Wiarda; E A van der Velde; E K Pauwels; F C Breedveld
Journal:  Rheumatol Int       Date:  1995       Impact factor: 2.631

9.  Prediction of erosiveness and rate of development of new erosions in early rheumatoid arthritis.

Authors:  T T Möttönen
Journal:  Ann Rheum Dis       Date:  1988-08       Impact factor: 19.103

10.  Serum N terminal procollagen III fragment: a predictive marker of joint destruction in rheumatoid arthritis?

Authors:  J G Tebib; P Viguier; E Noel; F Colson; Y Barbier; M Bouvier
Journal:  Clin Rheumatol       Date:  1992-12       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.